Spyre Therapeutics Other Long Term Assets (Quarterly) Analysis

Spyre Therapeutics, Inc. (SYRE)

44.18 +0.97 (+2.24%) USD | NASDAQ | Feb 23, 16:00

44.21 +0.03 (+0.07%) After-Hours: 19:59

View Other Long Term Assets (Quarterly) for SYRE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

PTC Therapeutics, Inc.	Upgrade
Tandem Diabetes Care, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade